Published in Immunotherapy Weekly, June 22nd, 1998
Joseph P. Eder Jr., representing colleagues from the Dana-Farber Cancer Institute, Harvard Medical School, Massachusetts; the U.S. National Cancer Institute, Maryland; and Therion Biologics Corporation, Massachusetts; presented phase I clinical trial results of PROSTVAC prostate cancer vaccine at the 34th Annual Meeting of the American Society of Clinical Oncology, held May 16-19, 1998, in Los Angeles, California (abstract "A Phase I Trial of Recombinant Vaccinia Virus, PROSTVAC, that...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Immunotherapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.